Peptide Synthesis Market Size, Share & Trends Analysis Report By Product Type (Reagents, Peptide Synthesizers, Resins), By Application (Drug Development, Research and Diagnostics, Therapeutics, Vaccine Development, Others (Cosmetics, Food, and Agriculture)), By End-User (Pharmaceutical and Biotech Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories), By Technology (Solid-Phase Peptide Synthesis (SPPS), Liquid-Phase Peptide Synthesis (LPPS), Hybrid Synthesis) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Dhanashri B | Format:

Market Segmentation

  1. Peptide Synthesis Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Reagents
    2. Peptide Synthesizers
    3. Resins
  2. Peptide Synthesis Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Drug Development
    2. Research and Diagnostics
    3. Therapeutics
    4. Vaccine Development
    5. Others (Cosmetics, Food, and Agriculture)
  3. Peptide Synthesis Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical and Biotech Companies
    2. Academic and Research Institutes
    3. Contract Research Organizations (CROs)
    4. Diagnostic Laboratories
  4. Peptide Synthesis Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Solid-Phase Peptide Synthesis (SPPS)
    2. Liquid-Phase Peptide Synthesis (LPPS)
    3. Hybrid Synthesis
  5. Regional Peptide Synthesis Market
    1. North America
      1. North America Peptide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
      2. North America Peptide Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Development
        2. Research and Diagnostics
        3. Therapeutics
        4. Vaccine Development
        5. Others (Cosmetics, Food, and Agriculture)
      3. North America Peptide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotech Companies
        2. Academic and Research Institutes
        3. Contract Research Organizations (CROs)
        4. Diagnostic Laboratories
      4. North America Peptide Synthesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Solid-Phase Peptide Synthesis (SPPS)
        2. Liquid-Phase Peptide Synthesis (LPPS)
        3. Hybrid Synthesis
      5. U.S.
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      6. Canada
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
    2. Europe
      1. Europe Peptide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
      2. Europe Peptide Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Development
        2. Research and Diagnostics
        3. Therapeutics
        4. Vaccine Development
        5. Others (Cosmetics, Food, and Agriculture)
      3. Europe Peptide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotech Companies
        2. Academic and Research Institutes
        3. Contract Research Organizations (CROs)
        4. Diagnostic Laboratories
      4. Europe Peptide Synthesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Solid-Phase Peptide Synthesis (SPPS)
        2. Liquid-Phase Peptide Synthesis (LPPS)
        3. Hybrid Synthesis
      5. U.K.
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      6. Germany
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      7. France
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      8. Spain
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      9. Italy
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      10. Russia
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      11. Nordic
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      12. Benelux
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      13. Rest of Europe
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
    3. APAC
      1. APAC Peptide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
      2. APAC Peptide Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Development
        2. Research and Diagnostics
        3. Therapeutics
        4. Vaccine Development
        5. Others (Cosmetics, Food, and Agriculture)
      3. APAC Peptide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotech Companies
        2. Academic and Research Institutes
        3. Contract Research Organizations (CROs)
        4. Diagnostic Laboratories
      4. APAC Peptide Synthesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Solid-Phase Peptide Synthesis (SPPS)
        2. Liquid-Phase Peptide Synthesis (LPPS)
        3. Hybrid Synthesis
      5. China
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      6. Korea
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      7. Japan
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      8. India
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      9. Australia
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      10. Taiwan
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      11. South East Asia
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      12. Rest of Asia-Pacific
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
    4. Middle East and Africa
      1. Middle East and Africa Peptide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
      2. Middle East and Africa Peptide Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Development
        2. Research and Diagnostics
        3. Therapeutics
        4. Vaccine Development
        5. Others (Cosmetics, Food, and Agriculture)
      3. Middle East and Africa Peptide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotech Companies
        2. Academic and Research Institutes
        3. Contract Research Organizations (CROs)
        4. Diagnostic Laboratories
      4. Middle East and Africa Peptide Synthesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Solid-Phase Peptide Synthesis (SPPS)
        2. Liquid-Phase Peptide Synthesis (LPPS)
        3. Hybrid Synthesis
      5. UAE
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      6. Turkey
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      7. Saudi Arabia
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      8. South Africa
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      9. Egypt
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      10. Nigeria
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      11. Rest of MEA
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
    5. LATAM
      1. LATAM Peptide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
      2. LATAM Peptide Synthesis Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Development
        2. Research and Diagnostics
        3. Therapeutics
        4. Vaccine Development
        5. Others (Cosmetics, Food, and Agriculture)
      3. LATAM Peptide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotech Companies
        2. Academic and Research Institutes
        3. Contract Research Organizations (CROs)
        4. Diagnostic Laboratories
      4. LATAM Peptide Synthesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Solid-Phase Peptide Synthesis (SPPS)
        2. Liquid-Phase Peptide Synthesis (LPPS)
        3. Hybrid Synthesis
      5. Brazil
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      6. Mexico
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      7. Argentina
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      8. Chile
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      9. Colombia
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis
      10. Rest of LATAM
        1. Reagents
        2. Peptide Synthesizers
        3. Resins
        4. Drug Development
        5. Research and Diagnostics
        6. Therapeutics
        7. Vaccine Development
        8. Others (Cosmetics, Food, and Agriculture)
        9. Pharmaceutical and Biotech Companies
        10. Academic and Research Institutes
        11. Contract Research Organizations (CROs)
        12. Diagnostic Laboratories
        13. Solid-Phase Peptide Synthesis (SPPS)
        14. Liquid-Phase Peptide Synthesis (LPPS)
        15. Hybrid Synthesis

We are featured on: